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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2014, KaohsiuAbstract Acetaminophen (APAP) is the most commonly reported toxic ingestion in the world.
Severe liver injury resulting from overdose or chronic use of APAP remains a significant clinical
problem. In recent years, the mechanisms underlying liver injury caused by APAP have become
much better understood. We have studied the protective effect of chitosan supplementation
against APAP-induced hepatotoxicity with respect to changes in the levels of total and lipid-
bound sialic acid in the serum and in the liver tissue and changes in the activity of diagnostic
marker enzymes, lipid peroxidation, and ceruloplasmin oxidase enzyme in normal and exper-
imental groups of rats. During the experimental period, chitosan (200 mg/kg body weight per
day) was administered to APAP þ chitosan-treated rats by oral gavage. Results showed that
treatment with APAP induced a significant increase in the serum alanine aminotransferase
and alkaline phosphatase activities, in total and lipid-bound sialic acids levels, and in the liver
lipid peroxide content. The administration of chitosan significantly prevented APAP-induced
alterations in the levels of diagnostic marker enzymes, total sialic acid, lipid-bound sialic acid,
and malondialdehyde in the experimental groups of rats. Furthermore, chitosan administration
increased the activity of ceruloplasmin oxidase. In conclusion, our results suggest that chitosan
has a protective effect on APAP-induced hepatic injury in rats. The study sheds light on the
therapeutic potential of chitosan in an APAP-induced hepatotoxicity model.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Acetaminophen (APAP) is a widely used analgesic with few
side effects when taken in therapeutic doses. Hepatotox-
icity is a common consequence of APAP overdose. Hepato-
toxicity may be predictable or unpredictable. Predictable
reactions typically are dose-related and occur in most
people shortly after reaching the threshold for toxicity.
Acetaminophen is a fairly predictable hepatotoxin, as are
chemicals that are no longer used as drugs such as carbon
tetrachloride, phosphorus, and chloroform [1,2]. In APAP
hepatotoxicity, biochemical signs of liver damage become
apparent within 24e48 hours after the time of overdose and
produce dose-related centrilobular necrosis in the liver
[2,3]. Early diagnosis of APAP hepatotoxicity is essential
because rapid deterioration is common, and current
treatments are very effective in preventing morbidity and
mortality [1,2].
The liver is a key organ that is responsible for many
critical functions within the body; if it becomes diseased or
injured, the loss of these functions can cause significant
damage to the body [4]. Several investigators have previ-
ously demonstrated that antioxidants prevent hepatotox-
icity by inhibiting lipid peroxidation [5] and by suppressing
the activity of AST and ALP [6]. Sialic acid (SA), a derivative
of neuraminic acid, is attached to the carbohydrate chains
of glycoproteins and glycolipids. The attachment of SA to
carbohydrate chains occurs in the liver. Therefore, it has
been hypothesized that liver function influences SA con-
centrations [7]. Studies have led to a better understanding
of the biological and pathological importance of SA.
Increased SA concentrations in various body fluids, espe-
cially in the blood serum, are observed in many patholog-
ical processes in which there is tissue damage, tissue
proliferation, and inflammation [8e10]. This shift occurs
because of the location and the ubiquitous distribution of
SA. Much research suggests that measuring the level of SA in
blood serum can predict the risk of various diseases [11,12].
A significant increase in SA concentrations has also been
observed during diabetes, cardiovascular diseases, chronic
liver disease, and liver malignancies. The mechanisms un-
derlying the elevated SA concentrations in different dis-
eases are unclear [13,14].
In recent years, several studies have examined the ef-
fects of antioxidants for supporting normal liver function
and for treating liver diseases. Antioxidants have recently
attracted much attention as useful alternative medicines
for treating or preventing lifestyle-related disorders; how-
ever, relatively little knowledge is available on their mode
of action [4]. Chitosan (CS), an important polysaccharide of
marine origin, is prepared from the shells of crustaceans. It
has attracted much attention as a biomedical material,
owing to its antitumor [15], antiulcer [16], immunostimu-
latory [17], and antibacterial activities [18]. In recent
years, the antioxidant activity of CS has attracted the most
attention. Studies show that CS has hepatoprotective ef-
fects related to antioxidant activity [19,20].
Hepatoprotective effects related to the antioxidant ac-
tivity of CS on APAP-induced hepatic injury have not pre-
viously been demonstrated. The present study investigated
the hepatoprotective effects of CS against APAP-inducedliver toxicity in rats by measuring lipid peroxidation; alka-
line phosphatase (ALP), alanine aminotransferase (ALT),
ceruloplasmin (Cp) oxidase enzyme activities; and total
sialic acid (TSA) and lipid-bound sialic acid (LSA) levels as
key indicators of hepatic detoxification.
Materials and methods
Chemicals
Acetaminophen, chitosan, N-acetylneuraminic acid, and
o-dianisidine dihydrochloride were obtained by Sigma
Chemical Co (St. Louis, MO, USA).
Animals
Spraque-Dawley male rats weighing 200e250 g were used
for the experiment. The animals were housed in poly-
propylene cages under hygienic conditions and maintained
at normal room temperature. The animals were allowed to
have food and water ad libitum. The experiment was
conducted in accordance with the guidelines of the
Experimental Research and Application Center of Medical
Sciences, Eskisehir Osmangazi University (Eskisehir,
Turkey) and approved by the Institutional Animal Ethics
Committee.
Experimental Design
The experimental animals were divided into four groups
of nine animals each. Group I rats (i.e., normal control)
were only administered the standard diet and water. In
Group II rats (i.e., APAP group), hepatotoxicity was
induced by 14 days of oral gavage with APAP (250 mg
each/kg body weight/day) [21]. In Group III rats (i.e., CS
group), the animals were treated by 14 days of oral
gavage with CS (200 mg/kg body weight/day) [19]. In
Group IV rats (APAP þ CS), the animals were treated for
14 days by oral gavage with APAP (250 mg each/kg body
weight/day) and 3 hours later with CS (200 mg/kg body
weight/day).
Preparation of serum and tissue samples
At the end of the experiment, the rats were anesthetized
with xylasin-ketamine and sacrificed 24 hours after the last
administration. Their blood was collected into biochemical
tubes by heart puncture. Blood samples were centrifuged
for 10 minutes at 3500 rpm (4000g) to obtain a clear
serum, which was stored at 80C. Serum samples were
used to determine the activities of ALT, ALP, and Cp
oxidase, and the levels of TSA, LSA, and total protein. The
liver tissue was excised immediately and washed with ice-
cold saline. A portion of liver tissue was homogenized with
0.1 M TriseHCl at pH 7.4, and the homogenate was used to
determine lipid peroxidation. A portion of liver tissue was
homogenized with 0.1 M phosphate buffer at pH 7.4. The
homogenates were used to determine the TSA and LSA
levels.
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Determination of ALT and ALP levels
Hepatotoxicity was assessed by quantifying the serum ac-
tivities of ALT and ALP. Serum ALT and ALP levels were
measured using a modular autoanalyzer (Roche, Mannheim,
Germany). Serum ALT and ALP activities were expressed by
units per liter (U/L).
Determination of TSA levels
Serum and tissue TSA levels were detected, as described by
the method of Sydow et al. [22]. In brief, 400-mL samples
were treated with 3 mL of 5% perchloric acid for 5 minutes
at 100C, and then centrifuged at 1400g for 4 minutes.
Two milliliters of the supernatant were mixed with 400 mL
of Ehrlich reagent (i.e., 5 g p-dimethylaminobenzaldehyde,
50 mL HCl, and 50 mL distilled water). After incubating at
100C for 15 minutes, 2 mL of distilled water were added to
the sample and a spectrophotometer (Shimadzu, UV-1601,
Kyoto, Japan) was used to read the optical density at a
wavelength of 525 nm [23].
Determination of LSA levels
Serum and tissue LSA levels were measured, as described by
Katopodis et al. [24]. In brief, 50-mL samples were extrac-
ted with chloroform:methanol (2:1 v/v) maintained at 4C.
The lipid extract was separated with 0.5 mL of distilled
water. The aqueous layer was precipitated with phospho-
tungstic acid. The precipitates were resuspended in 1 mL of
distilled water, and the presence of LSA in the suspension
was determined with resorcinol reagent. The LSA contents
were calculated using standard curves obtained for various
concentration of N-acetyl neuraminic acid.
Determination of Cp oxidase activity
Serum Cp oxidase activity, using o-dianisidine dihydro-
chloride as the substrate, was determined spectrophoto-
metrically by one technician, as described previously by
Schosinsky et al. [25]. All measurements were performed in
duplicate. The enzymatic activity of Cp was expressed in
international units (IU) in the substrate consumed by the
formula:[26]
Cp oxidase activityZðA15  A5Þ  6:25 102 U=L
Determination of malondialdehyde levels
The tissue level of malondialdehyde (MDA) was measured in
accordance with the method of Ohkawa et al. [27].
Protein measurement
Protein was assayed by the method of Bradford [28] (1976)
using serum bovine albumin as the standard.
Statistical analysis
All data analyses were performed by using SPSS Statistics 20
(SPSS Inc, Chicago, USA) and SigmaStat 3.5 (Chicago, IL, USA).
The descriptive statistics were demonstrated by n (i.e., the
sample size) and by the mean and standard deviation for
continuous variables. Continuous normally distributed mea-
surementswere compared across the groups by using one-wayanalysis of variance (ANOVA) with the Tukey method and the
Student-Newman-Keuls method multiple comparisons. A
p < 0.05 was accepted as significant.Results
In the APAP group, the levels of ALT, ALP, TSA, LSA, and MDA
were significantly higher (p < 0.001), compared to the con-
trol group and the CS-treated groups (Table 1). The Cp oxi-
dase activity was decreased significantly (p < 0.001) in the
APAP-treated group, compared to the control group and the
CS-treated group. In the APAP þ CS group the levels of ALT,
ALP, TSA, LSA, and MDAwere significantly lower (p< 0.001),
compared to the APAP group. However, the activity of Cp
oxidase was statistically higher (p < 0.001) in the APAPþCS
group than in the APAP group (Table 1). Treatment with CS
offered a protective effect against increased levels of ALT,
ALP, TSA, LSA, MDA induced by APAP.Discussion
In this study, we defined hepatotoxicity as injury to the
liver that is associated with impaired liver function caused
by exposure to APAP. The liver is an important organ in the
body because it provides protection from potentially inju-
rious exogenous and endogenous compounds. It is affected
through this process. Thus, the protective mechanisms of
the liver are of special concern [20]. Researchers are
investigating natural products to explore their pharmaco-
logical features such as hepatoprotective, antioxidant, and
anti-inflammatory activities. Several natural antioxidants
reduce oxidative stress and protect from hepatic damage.
Chitosan has attracted much attention as a biomedical
material, owing to its antitumor, antiulcer, immunostimu-
latory, antibacterial, and other unique biological activities.
Chitosan’s antioxidant activity has recently attracted the
most attention [15,16,19,29].
Acetaminophen-induced hepatic damage is the second
leading cause of liver transplantation and accounts for
considerable levels of morbidity and mortality.
The advantage of this model is that experiments are
technically easy to perform because APAP is a dose-
dependent toxicant and, most importantly, it is clinically
relevant [30].When themembrane of a liver cell is damaged,
a variety of cytosolic enzymes are released into the blood-
stream. The estimation of enzymes in the serum is a useful
quantitative marker of the extent and the type of hepato-
cellular damage [31]. In this study, abnormally high activities
of serum ALT and ALP after APAP administration is an indi-
cation of the development of hepatic damage, which is
responsible for the leakage of cellular enzymes into the
blood. When liver plasma membranes become damaged, a
variety of enzymes that are normally located in the cytosol
are released into the circulation. The present study sug-
gested the ameliorative effect of CS on the activity of ALT
and ALP against APAP-induced changes in rats. The observed
reduction in the levels of liver function enzymes as a result of
CS administration may result, in part, from the presence of
antioxidant compounds that aid in reducing APAP-induced
liver damage. This effect was possibly because of the
Table 1 Biochemical characteristics of the groups.
Control (n Z 9) Chitosan (n Z 9) APAP (n Z 9) APAP þ CS (n Z 9)
ALT (U/L) 28.89  7.08 33.33  7.29c 174.33  15.77a 83.44  14.32b
ALP (U/L) 157.78  15.77 150.00  11.03c 480.67  57.32a 254.00  34.27b
Serum TSA (mg/mg protein) 39.11  8.45 25.36  6.34d 84.88  8.96a 37.06  5.81b
Serum LSA (mg/mg protein) 19.95  3.63 16.20  2.14c 52.33  3.69a 21.64  5.57b
Tissue TSA (mg/dL) 8.18  1.61 8.47  2.19c 31.21  6.89a 19.76  2.50b
Tissue LSA (mg/dL) 6.28  1.94 4.51  2.31c 21.66  3.60a 12.89  4.20b
Ceruloplasmin oxidase (U/L) 38.19  7.61 33.45  11.73c 20.04  8.70a 40.50  12.55b
MDA (nmol/mg protein) 7.73  3.58 8.62  3.11c 36.55  4.71a 19.98  2.45b
Normally distributed values are expressed as the mean  standard deviation (n Z 9 in each group).
ALPZ alkaline phosphatase; ALTZ aspartate aminotransferase; APAPZ acetaminophen; CSZ chitosan; LSAZ lipid bound sialic acid;
MDA Z malondialdehyde; TSA Z total sialic acid.
a p < 0.001, significantly different from the control group.
b p < 0.001, significantly different from the APAP group.
c p > 0.05, not significantly different from the control group.
d p < 0.05, significantly different from the control group.
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endogenous antioxidant defense status [6,13,32].
Lipid peroxidation is regarded as an important initiation
event in the toxicity mechanism of APAP. It is well docu-
mented that the liver tissue contains a relatively high content
of polyunsaturated fatty acids (PUFAs), which are sensitive to
peroxidative damage. The toxicity of APAP depends on the
conversion of APAP into the toxic metabolite N-acetyl-p-
benzoquinone imine (NAPQI) by cytochrome P540, which
leads to hepatocellular damage. Lipid peroxidation may be a
major pathway of disease initiation and proliferation.
Increased lipidperoxidationand impairedantioxidantenzyme
function in the liver tissue are characteristic observations in
APAP-treated rats [33,34]. In the present study, increased
lipid peroxidationdas evidenced by elevated levels of MDA in
hepatic tissues after the administration of APAPdcould be
expected owing to the depletion of endogen antioxidant
stores. Recent studies show that CS has a scavenging effect.
The scavenging effect of CS on hydroxyl radicals inhibits lipid
peroxidation of phosphatidylcholine and linoleate liposomes.
Chitosan could prevent liver damage. In this study, the con-
centration of MDA decreased significantly after CS adminis-
tration. Chitosan moreover decreased the ALT and ALP
enzyme activities. Lipid peroxidation changes membrane
integrity, thereby impairing major metabolic functions that
depend on membrane structure and integrity. These results
clearly showed that the antioxidant action of CS significantly
reduces APAP-induced liver damage. Furthermore, CS has an
important effect on inhibiting lipid peroxidation [19].
The liver secretes into the circulation numerous glyco-
proteins, all of which are sialylated on the termini of their
glycans. As mentioned earlier, the addition of these sialic
acids assures the survival of these serum proteins, and their
removal can result in a rapid clearance that is mediated by
hepatic receptors that recognize the underlying sugar
chain. This is also of relevance in biotechnology in that
many biotherapeutic agents must be produced as glyco-
proteins, which require adequate SA capping of their gly-
cans to avoid rapid clearance [24].
The attachment of SA to carbohydrate chains occurs in
the liver. Therefore, it has been hypothesized that liver
function influences SA concentrations [7]. Several researchstudies show that SA concentrations are elevated in path-
ological states in which there is tissue damage, tissue
proliferation, and inflammation; an increase in SA levels
may reflect an acute phase response [35,36]. In this study,
serum and tissue levels of TSA and LSA were significantly
increased only in the APAP group of rats.
Chitosan administration significantly prevented the in-
crease in the TSA and LSA levels. Based on these results, we
believe that lipid peroxidation develops as a result of tissue
damage in APAP-induced toxicity. At the same time, the
increased production of LSA from the surface of the cell
membrane results from increased sialoprotein synthesis in
the liver. As a result, the TSA levels rise. Chitosan is highly
positively charged; it may adhere to cell membranes and
evoke some biological change in the cell membrane [37].
The present findings suggest that CS does not induce lipid
peroxidation. Therefore, CS could interact with the cell
membrane to decrease SA levels, and CS treatment could
reduce the development of liver damage.
Ceruloplasmin is a copper-containing protein and is pri-
marily synthesized in the liver. It is a ferroxidase enzyme. It
plays a role in the transport of copper, modulation of coagu-
lation, inactivation of biogenic amines, and defense against
oxidative stress. Ceruloplasmin prevents the formation of
oxygen-free radicals and lipid peroxidation; thus, it blocks
free radical damage in tissue and in plasma [38,39]. Our re-
sults revealed that the activity of Cp oxidase was significantly
decreased in the APAP-induced toxicity group, compared to
the control group. The present findings suggest that Cp oxi-
dase activity is inhibited in liver damage. Decreased Cp oxi-
dase activity may contribute to the induction of oxidative
stress. In this study, Cp oxidase activity was also increased in
the serum after CS treatment. We have observed the stimu-
latory effect of CS treatment on Cp oxidase activity.
Based on the aforementioned results, it may be that CS
has a significant protective effect on APAP-induced liver
damage, it reduces lipid peroxidation and SA levels, and it
improves endogenous antioxidant defense systems. This
study showed biological evidence that supports using CS in
the treatment of APAP-induced hepatotoxicity. Hence, CS
could be used as an effective protector against APAP-
induced damage.
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